The short answer
Folic acid is commonly co-prescribed with low-dose weekly methotrexate for inflammatory disease, often on a different day. Follow the prescriber's specific schedule: this guidance must not be applied to cancer, ectopic pregnancy, overdose or other specialist methotrexate regimens.
What this answer covers
Applies to clinician-directed folic acid with low-dose weekly systemic methotrexate for inflammatory disease; folinic acid and rescue protocols are separate.
- Supplement or preparation
- Folic acid
- Medication ingredient
- methotrexate
Evidence and practical considerations
Timing & monitoring
Current labeling and a 2025 rheumatology guideline make clinician-directed folic acid a high-confidence co-use requirement during low-dose weekly inflammatory-disease methotrexate. The guideline provides a commonly used separate-day schedule, while oncology labeling requires the opposite caution. The conclusion is supported with conditions rather than a universal timing instruction.
- Exact scope
- folic acid with methotrexate
- Medication form and route
- low-dose weekly systemic methotrexate for inflammatory disease; neoplastic and ectopic-pregnancy regimens require separate specialist instructions
- Timing or duration
- Folic acid is co-prescribed throughout chronic low-dose treatment; timing recommendations commonly avoid the methotrexate day, while oncology and post-exposure instructions are protocol specific.
What remains uncertain
- The 2025 BSR guideline recommends avoiding the methotrexate day, while the current US label directs supplementation without a universal day; local instructions may differ.
- Non-neoplastic folate co-prescription must not be transferred to cancer, ectopic-pregnancy, overdose, or intrathecal regimens.
- An ordinary multivitamin containing folic acid is not a substitute for the prescriber's specified folic-acid dose.
- Folic acid and folinic acid are separate counterparty records because rescue strength and timing differ.
Factors that may matter: neoplastic versus non-neoplastic indication; agreed weekly methotrexate dosing day; folic-acid dose and adherence; baseline folate status; pregnancy or recent methotrexate exposure; toxicity symptoms and laboratory trends.
Read the supporting source summaries
Source 1: current United States prescribing information
accessdata.fda.gov · Source check Jul 25, 2026
Population: Adults and pediatric patients receiving oral methotrexate for labeled neoplastic or non-neoplastic indications.
The label directs folic or folinic acid in rheumatoid arthritis, pJIA, and psoriasis but tells neoplastic-disease patients not to use folate products unless directed.
The label does not specify an optimal folic-acid day or dose for every non-neoplastic indication.
Source 2: 2025 evidence-based rheumatology guideline
academic.oup.com · Source check Jul 25, 2026
Population: Adults and children receiving conventional synthetic DMARDs in rheumatology practice, including low-dose methotrexate.
The guideline recommends an agreed weekly methotrexate day and at least 5 mg folic acid once weekly, not on the methotrexate day, with unanimous agreement.
Rheumatology-specific; the guideline acknowledges insufficient evidence for the optimal folic-acid day beyond avoiding the methotrexate day in trials.
Source 3: United Kingdom professional medicines guidance
sps.nhs.uk · Source check Jul 25, 2026
Population: Adults with rheumatoid arthritis receiving low-dose weekly methotrexate in routine UK practice.
The most common regimen is folic acid 5 mg once weekly on a different day; dose may increase to 10 mg if adverse effects persist, under prescriber direction.
Off-label folic-acid use and rheumatology context; alternative schedules exist and oncology is outside scope.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Research summary published |
Article revision: ef29ad0bbee026e4
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.